CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Medy-Tox Incorporation Company Snapshot
Medy-Tox Incorporation operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medy-Tox Incorporation with three other companies in this sector in South Korea: Choong Ang Vaccine Laboratory (2016 sales of 37.90 billion Korean Won [US$33.92 million] ), Komipharm International Company Limited (37.64 billion Korean Won [US$33.68 million] of which 100% was Animal Pharmaceutical), and Cell Biotech Co ., Limited. (58.28 billion Korean Won [US$52.16 million] ).

Sales Analysis. During the year ended December of 2016, sales at Medy-Tox Incorporation were 133.26 billion Korean Won (US$119.26 million). This is an increase of 50.6% versus 2015, when the company's sales were 88.51 billion Korean Won. This was the fifth consecutive year of sales increases at Medy-Tox Incorporation (and since 2011, sales have increased a total of 514%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Medy-Tox Incorporation
  Stock Performance Chart for Medy-Tox Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 418,100
(Figures in Korean Won)
1 Week 2.5%   13 Weeks 0.0%  
4 Weeks 21.3%   52 Weeks -2.5%  
 
Medy-Tox Incorporation Key Data:
  Ticker: 086900 Country: Korea (South)
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 133,255,671,034
(Year Ending Jan 2017).
Employees: 280
  Currency: Korean Won Market Cap: 2,214,481,283,500
  Fiscal Yr Ends: December Shares Outstanding: 5,296,535
  Share Type: Common Closely Held Shares: 2,275,687
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.